Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7820)
All Articles published online
|
Publishing Process of This Article
|
May 14, 2015 (publication date) through Feb 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou DS, Xu L, Luo YL, He FY, Huang JT, Zhang YJ, Chen MS. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization. World J Gastroenterol 2015; 21(18): 5582-5590 [PMID: 25987783 DOI: 10.3748/wjg.v21.i18.5582] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i18/5582.htm |
| Number | Citing Articles |
| 1 |
Mohamad Mouchli, Shravani Reddy, Miranda Gerrard, Lisa Boardman, Marrieth Rubio. Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review article. Annals of Hepatology 2021; 22: 100249 doi: 10.1016/j.aohep.2020.08.067
|
| 2 |
Yongzhao Zhao, Guangyan Si, Fengshang Zhu, Jialiang Hui, Shangli Cai, Chenshen Huang, Sijin Cheng, Abdel Hamid Fathy, Yi Xiang, Jing Li. Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget 2017; 8(14): 22854 doi: 10.18632/oncotarget.15281
|
| 3 |
Jian-Jun Gao, Zhen-Yan Shi, Ju-Feng Xia, Yoshinori Inagaki, Wei Tang. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12059-12070 doi: 10.3748/wjg.v21.i42.12059
|
| 4 |
Isabel Theresa Schobert, Lynn Jeanette Savic, Julius Chapiro, Khaled Bousabarah, Evan Chen, Fabian Laage-Gaupp, Jonathan Tefera, Nariman Nezami, MingDe Lin, Jeffrey Pollak, Todd Schlachter. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE. European Radiology 2020; 30(10): 5663 doi: 10.1007/s00330-020-06931-5
|
| 5 |
Lingling Lu, Kunzhe Lin, Jiaolong Zheng, Haicong Wu, Dongliang Li. Glasgow Prognostic Score and modified Glasgow Prognostic Score and survival in patients with hepatocellular carcinoma: a meta-analysis. BMJ Open 2021; 11(12): e053061 doi: 10.1136/bmjopen-2021-053061
|
| 6 |
|
| 7 |
Chao-Bin He, Xiao-Jun Lin, Sheng-Nan Lu. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101. PLOS ONE 2017; 12(3): e0174769 doi: 10.1371/journal.pone.0174769
|
| 8 |
Ying Liu, Menting Shi, Shuanggang Chen, Weiqi Wan, Lujun Shen, Binyan Shen, Han Qi, Fei Cao, Ying Wu, Tao Huang, Guanjian Chen, Jinqing Mo, Dongdong Ye, Yinqi Zhang, Ziqing Feng, Weijun Fan. Intermediate stage hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 2021; 17(3): 740 doi: 10.4103/jcrt.jcrt_29_21
|
| 9 |
Yu-chen Wei, Liang yun, Yan-ling Liang, Robert Grimm, Chongze Yang, Yuan-fang Tao, Sheng-chen Jiang, Jin-yuan Liao. Nomogram based on the neutrophil-to-lymphocyte ratio and MR diffusion quantitative parameters for predicting Ki67 expression in hepatocellular carcinoma from a prospective study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-82333-7
|
| 10 |
Xingshun Qi, Jianjun Li, Han Deng, Hongyu Li, Chunping Su, Xiaozhong Guo. Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies. Oncotarget 2016; 7(29): 45283 doi: 10.18632/oncotarget.9942
|
| 11 |
Shuxin Sun, Chaobin He, Jun Wang, Xin Huang, Jiali Wu, Shengping Li. The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07482-0
|
| 12 |
Liang-He Lu, Wei Wei, Shao-Hua Li, Yong-Fa Zhang, Rong-Ping Guo. The lymphocyte-C-reactive protein ratio as the optimal inflammation-based score in patients with hepatocellular carcinoma underwent TACE. Aging 2021; 13(4): 5358 doi: 10.18632/aging.202468
|
| 13 |
Yossi Ventura, Brian I Carr, Issac Kori, Vito Guerra, Oren Shibolet. Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization. World Journal of Gastroenterology 2018; 24(15): 1641-1649 doi: 10.3748/wjg.v24.i15.1641
|
| 14 |
Brian I. Carr, Vito Guerra. Serum Albumin Levels in Relation to Tumor Parameters in Hepatocellular Carcinoma Patients. The International Journal of Biological Markers 2017; 32(4): 391 doi: 10.5301/ijbm.5000300
|
| 15 |
Bibek Aryal, Munekazu Yamakuchi, Toshiaki Shimizu, Jun Kadono, Akira Furoi, Kentaro Gejima, Teruo Komokata, Teruto Hashiguchi, Yutaka Imoto. Deciphering Platelet Kinetics in Diagnostic and Prognostic Evaluation of Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/9142672
|
| 16 |
Zhen-Xin Zeng, Jia-Yi Wu, Jun-Yi Wu, Zhi-Bo Zhang, Kai Wang, Shao-Wu Zhuang, Bin Li, Jian-Yin Zhou, Zhong-Tai Lin, Shu-Qun Li, Yi-Nan Li, Yang-Kai Fu, Mao-Lin Yan. Prognostic Value of Pathological Response for Patients with Unresectable Hepatocellular Carcinoma Undergoing Conversion Surgery. Liver Cancer 2024; 13(5): 498 doi: 10.1159/000536376
|
| 17 |
Han Cheng, Sandeep Bhushan, Na Li, Zongwei Xiao, Ke Gao. Preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are correlated with tumor–node–metastasis stages in patients with non-small cell lung cancer. Journal of Cancer Research and Therapeutics 2022; 18(6): 1666 doi: 10.4103/jcrt.jcrt_473_21
|
| 18 |
Shaodi Wen, Yuzhong Chen, Chupeng Hu, Xiaoyue Du, Jingwei Xia, Xin Wang, Wei Zhu, Qingbo Wang, Miaolin Zhu, Yun Chen, Bo Shen. Combination of Tertiary Lymphoid Structure and Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients With Hepatocellular Carcinoma. Frontiers in Immunology 2022; 12 doi: 10.3389/fimmu.2021.788640
|
| 19 |
Mu-xing Li, Xin-yu Bi, Zhi-yu Li, Zhen Huang, Yue Han, Jian-guo Zhou, Jian-jun Zhao, Ye-fan Zhang, Hong Zhao, Jian-qiang Cai. Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma. Medicine 2015; 94(49): e2133 doi: 10.1097/MD.0000000000002133
|
| 20 |
Ilze Strumfa, Dzeina Mezale, Boriss Strumfs, Andrejs Vanags, Arturs Kalva, Dainis Balodis, Ilze Fridrihsone, Arnis Abolins, Janis Gardovskis. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment. 2018; doi: 10.5772/intechopen.76599
|
| 21 |
Leung Li, Stephen L. Chan, Frankie Mo, Edwin P. Hui, Jane Koh, Allen KC Chan, Nelson LS Tang, Cheuk M. Chu, Joyce Hui, Kit F. Lee, Simon Yu, Winnie Yeo. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients. Quality of Life Research 2019; 28(9): 2597 doi: 10.1007/s11136-019-02190-0
|
| 22 |
Ross D. Dolan, Donald C. McMillan. The prevalence of cancer associated systemic inflammation: Implications of prognostic studies using the Glasgow Prognostic Score. Critical Reviews in Oncology/Hematology 2020; 150: 102962 doi: 10.1016/j.critrevonc.2020.102962
|